InvestorsHub Logo
Followers 1
Posts 347
Boards Moderated 0
Alias Born 12/09/2016

Re: Meishairwin post# 18319

Saturday, 04/15/2017 12:49:07 AM

Saturday, April 15, 2017 12:49:07 AM

Post# of 108192
Meishairwin, you are right, everyone invested needs to take the time to listen to that presentation. I was very impressed with the data discussion about AXAL+durvalumab and extremely impressed with the neoepitope technology discussion. We have some top notch employees working for Advaxis for sure! Could you sense the tone in (forgot his name) when talking about Aduro's approach (and "most" other companies using the algorithm approach) with their 9 antigen algorithm compared to our potential 100 antigen delivery? Plus all the other areas of focus ADXS is branching out to that they discussed...I was bouncing off my chair listening to it. I admit, the talk was way above my pay grade which is why it took me 2 1/2 hrs to listen to the whole thing after rewinding multiple times, but wow! They also mentioned having a product approved in EU by this time (ish) next year. Not to much about k9 osteosarcoma, of coarse, but wow this company is legit in the short and long term!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News